what are glp-1 agonists receptor for individualized treatment of type 2 diabetes mellitus America's Poison Centers - GLP-1

Gastroenterol Hepatol (N Y)

Comparative effectiveness of sodiumglucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes

Motivations for treatment switch cannot be determined retrospectively

Weekly injectables (semaglutide, dulaglutide) require one injection per week

Severe gastrointestinal disease, particularly gastroparesis, may alter both efficacy and tolerability and requires careful consideration

14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment